Back

Clonal hematopoiesis of indeterminate potential and stress hyperglycemia ratio among patients with STEMI---from a prospective cohort study

29 August 2026 (14:15 - 14:45)
Organised by: Logo
Congress Presentation Part of: Acute myocardial infarction: contemporary challenges ST-Elevation Myocardial Infarction (STEMI) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Linghan Xue

(China)

4 More presentations in this session

Presentation thumbnail
Impact of coronary artery ectasia on revascularization strategies and echocardiographic characteristics in patients presenting with ST-segment elevation myocardial infarction
Doctor L. Caunite (Leiden, NL)
Abstract
Presentation thumbnail
Contemporary heart failure and mortality burden after STEMI: insights from a real-world cohort
Doctor R. Aggarwal (Boston, US)
Abstract
Presentation thumbnail
Selection matters: clinical indication, not timing, determines angiographic success in late-presenting STEMI
Doctor A. Zambrano Zambrano (Mexico City, MX)
Abstract
Presentation thumbnail
Comparative clinical outcomes of nebivolol versus bisoprolol in patients with STEMI after primary PCI: a propensity-score matched analysis
Professor J. Park (Deajeon, KR)
Abstract

Access the full session

Session thumbnail
Acute myocardial infarction: contemporary challenges

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic significance of clonal haematopoiesis of indeterminate potential-mutations with inflammation biomarkers in patients with STEMI
30 August 2025
thumbnail
Congress Presentation
Stress hyperglycemia: a predictor of major adverse cardiac events in non-diabetic patients with acute heart failure
21 May 2023
thumbnail
Congress Presentation
Hematological risk factors in myocardial infarction: a comprehensive analysis from STRONG-MI
1 September 2025
thumbnail
Congress Presentation
Clonal hematopoiesis of indeterminate potential in atrial fibrillation: prevalence and an association with progression
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources